Cadila Healthcare has informed that it has enclosed a copy of press release dated February 5, 2021 titled ‘Zydus completes large scale enrolment for two Phase III trials of Desidustat’. The contents of the press release give full details. Bring the aforesaid news to the notice of the members of the exchange and the investors at large.
The above information is a part of company’s filings submitted to BSE.